Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Dine Brands Global
DIN
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By geography
See full
Domestic
24.5%
+2.5%
Other financials
Income statement
See full
Revenue
$225.2M
+4.8%
Gross profit
$142.9M
+7.0%
Net income
$7.4M
-9.8%
EPS (diluted)
$0.57
+7.5%
Balance sheet
See full
Cash & equivalents
$172.9M
-31.0%
Total debt
$1.6B
-0.2%
Total equity
-$290.0M
-34.4%
Total assets
$1.7B
-4.4%
Cash flow
See full
Operating cash flow
$7.5M
-53.4%
CapEx
$12.1M
+267%
Free cash flow
-$4.6M
-136%
Valuation
See full
Market cap
$431.42M
+1.5%
Enterprise value
$1.87B
+4.5%
P/E
11.7×
+6.4×
P/S
0.5×
0.0×
Profitability
See full
Gross margin
63.5%
+4.3pp
Net margin
4%
-7.4pp
FCF margin
10.2%
-3.8pp
Returns & leverage
See full
Return on equity
32.8%
—
Debt / equity
5.2×
—
Current ratio
0.9×
0.0×